University College London (UCL) Researcher Advances Knowledge in Disease Progression ("Paradoxical" Cerebral Volume Changes in Anti-Amyloid Immunotherapy Trials).

MLA

“University College London (UCL) Researcher Advances Knowledge in Disease Progression (‘Paradoxical’ Cerebral Volume Changes in Anti-Amyloid Immunotherapy Trials).” Immunotherapy Weekly, Feb. 2025, p. 2706. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=182829605&authtype=sso&custid=ns315887.

APA

University College London (UCL) Researcher Advances Knowledge in Disease Progression (“Paradoxical” Cerebral Volume Changes in Anti-Amyloid Immunotherapy Trials). (2025). Immunotherapy Weekly, 2706.

Chicago

“University College London (UCL) Researcher Advances Knowledge in Disease Progression (‘Paradoxical’ Cerebral Volume Changes in Anti-Amyloid Immunotherapy Trials).” 2025. Immunotherapy Weekly, February, 2706. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=182829605&authtype=sso&custid=ns315887.